Jun 6 |
Shareholders in Pharming Group (AMS:PHARM) are in the red if they invested a year ago
|
Jun 3 |
Pharming Group to participate in June investor conferences
|
May 30 |
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
|
May 21 |
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
|
May 20 |
Pharming Group to participate in May investor conference
|
May 15 |
Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
|
May 12 |
Pharming Group N.V. 2024 Q1 - Results - Earnings Call Presentation
|
May 12 |
Pharming Group N.V. (PHAR) Q1 2024 Earnings Call Transcript
|
May 8 |
Pharming reports Q1 results
|
May 8 |
Pharming GAAP EPS of -$0.01 misses by $0.02, revenue of $55.6M misses by $14.47M
|